Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02401230 · ClinicalTrials.gov registry record · Phase 4
PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 86
- Enrollment target
NCT02401230 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 86 participants.
The verdict
NCT02401230, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the use of rectal lubricants can affect how well the medication, Truvada, will work to prevent infection with HIV when someone is exposed to HIV in the rectum.
Interventions
- DRUG Truvada
- DEVICE Gel lubricant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-01-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02401230
The ClinicalTrials.gov registry entry for NCT02401230 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Truvada is the first listed.
NCT02401230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02401230 about?
NCT02401230 is a clinical study titled "PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV". The purpose of this study is to determine whether the use of rectal lubricants can affect how well the medication, Truvada, will work to prevent infection with HIV when someone is exposed to HIV in the rectum.
What is the current status of trial NCT02401230?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. The study started on 2015-03. Estimated completion is 2017-01-25.
What interventions are being tested in trial NCT02401230?
The interventions under investigation include: Truvada (DRUG), Gel lubricant (DEVICE).
Who is sponsoring clinical trial NCT02401230?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.